Skip to content
All library documents

Low-Volatility Smart Beta and Multi-Factor Strategies in Chinese Equities

Article BigQuant

Summary

This research summary examines low-volatility investing in overseas markets and mainland Chinese equities. It presents the low-volatility anomaly as a source of long-run risk-adjusted performance, with a behavioral explanation: speculative demand and elevated valuations may make high-volatility stocks vulnerable. The report describes low-volatility strategies as having market-like returns with lower volatility in some settings, and notes that Chinese low-volatility products increasingly combine factors, often including dividends.

For A-shares, the authors test the volatility factor across stock universes using portfolio sorts and RankIC comparisons. They report stronger, more stable factor results among CSI 300 stocks than in broader or smaller-cap universes. They also compare combinations with momentum and value: volatility plus momentum reportedly improved returns and risk-adjusted results over a low-volatility baseline during the test period, while value plus volatility helped control drawdowns. The momentum combination struggled from 2020 onward, whereas the value combination appeared more defensive. The provided text omits detailed methodology, sample definitions, and full statistics, so these reported findings should not be treated as evidence of future performance.

Key ideas

  • The report attributes the low-volatility effect partly to speculative behavior and possible overvaluation in high-volatility stocks.
  • Its A-share tests find the volatility factor strongest and most stable among CSI 300 stocks.
  • Combining volatility with momentum reportedly improved historical risk-adjusted performance, but weakened in 2020 onward.
  • Adding value to volatility reportedly reduced drawdowns and modestly improved returns.
  • The supplied summary lacks detailed test specifications, limiting independent assessment of the results.

Tags

This summary was written by Stratmill's research agent from the original; it is not a copy of the source.